Back
C4 Therapeutics Stock Price Chart
Sponsored
CCCC
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
24
CCCC
C4 Therapeutics
Last Price:
6.87
Seasonality Move:
19.96%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCCC is experiencing slight selling pressure.
C4 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.29 | Buy |
20-day SMA: | 6.24 | Buy |
50-day SMA: | 6.16 | Buy |
200-day SMA: | 6.28 | Buy |
8-day EMA: | 6.3 | Buy |
20-day EMA: | 6.2 | Buy |
50-day EMA: | 6.06 | Buy |
200-day EMA: | 5.85 | Buy |
C4 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 53.46 | Buy |
Chaikin Money Flow: | -188709 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.84 - 6.52) | Buy |
Bollinger Bands (100): | (4.95 - 6.51) | Buy |
C4 Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for C4 Therapeutics Stock
Is C4 Therapeutics Stock a Buy?
- C4 Therapeutics share price is 6.39 while CCCC 8-day simple moving average is 6.29, which is a Buy signal.
- The stock price of CCCC is 6.39 while C4 Therapeutics 20-day SMA is 6.24, which makes it a Buy.
- C4 Therapeutics 50-day simple moving average is 6.16 while CCCC share price is 6.39, making it a Buy technically.
- CCCC stock price is 6.39 and C4 Therapeutics 200-day simple moving average is 6.28, creating a Buy signal.
CCCC Technical Analysis vs Fundamental Analysis
Sell
24
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics a Buy or a Sell?
-
C4 Therapeutics stock is rated a Sell
The current C4 Therapeutics [CCCC] share price is $6.39. The Score for CCCC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
C4 Therapeutics Stock Info
Market Cap:
442.72M
Price in USD:
6.39
Share Volume:
926.39K
C4 Therapeutics 52-Week Range
52-Week High:
11.88
52-Week Low:
1.06
Sell
24
C4 Therapeutics (CCCC)
is a Sell
C4 Therapeutics Share Price Forecast
-
What is the C4 Therapeutics stock price today?
The C4 Therapeutics stock price is 6.39 USD today. -
Will CCCC stock go up or go down?
C4 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is C4 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, C4 Therapeutics is overvalued.
Is C4 Therapeutics Stock a Buy?
- C4 Therapeutics share price is 6.39 while CCCC 8-day exponential moving average is 6.30, which is a Buy signal.
- The stock price of CCCC is 6.39 while C4 Therapeutics 20-day EMA is 6.20, which makes it a Buy.
- C4 Therapeutics 50-day exponential moving average is 6.06 while CCCC share price is 6.39, making it a Buy technically.
- CCCC stock price is 6.39 and C4 Therapeutics 200-day simple moving average is 5.85, creating a Buy signal.
Fundamental Analysis of C4 Therapeutics
Is C4 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.03 per share, an increase this year of $1.53 per share, and a decrease next year of $0.31 per share.
Technical Analysis of C4 Therapeutics
Should I short C4 Therapeutics stock?
- CCCC Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting C4 Therapeutics is a Buy
- C4 Therapeutics Relative Strength Index (RSI) is 53.46, which suggest C4 Therapeutics is overbought
- The Bollinger Bands (25) for C4 Therapeutics is (5.84 - 6.52), which suggest C4 Therapeutics is a Buy
- The Bollinger Bands (100) for C4 Therapeutics is (4.95 - 6.51), which suggest C4 Therapeutics is a Buy
* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.